Global Diabetes Treatment Devices Market Worth $15.61 Billion by 2029, Growing at 6.1% CAGR

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

Diabetes Treatment Devices Market Outlook: What Size And CAGR Are Anticipated By 2025?
The market for diabetes treatment devices has seen substantial growth in recent years. It is projected to expand from a size of $11.61 billion in 2024 to $12.34 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%. Key factors driving this growth during the historic period include an increase in diabetes cases, enhanced public understanding of diabetes management, increased use of insulin delivery devices, elevated healthcare spending in emerging economies, and the increased availability and accessibility of superior glucose monitoring systems.

What Is the Expected CAGR for the Diabetes Treatment Devices Market Growth Through 2029?
In the coming years, robust expansion is anticipated for the diabetes treatment devices market, which is projected to reach a value of $15.61 billion by 2029, climbing at a compound annual growth rate (CAGR) of 6.1%. This projected growth during the forecast period can be linked to the rising demand for wearable and non-invasive monitoring tools, the increased attention towards personalized diabetes care, the escalating usage of digital health platforms and applications, the burgeoning demand for remote diabetes management services, and escalating government efforts to promote diabetes control programs. Key trends expected during the forecast period include advancements in the technology of continuous glucose monitoring, innovation in insulin delivery systems incorporating artificial intelligence, the rise of intelligent wearable devices for diabetes, breakthroughs in non-invasive blood sugar monitoring, and the incorporation of voice assistants in device handling.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

What Are the Primary Drivers Behind Diabetes Treatment Devices Market Growth?
The escalation in the prevalence of obesity is anticipated to stimulate the expansion of the market for diabetes treatment devices. The term obesity rate is tied to the proportion of people designated as obese according to their Body Mass Index (BMI). This rise is largely attributed to unhealthy dietary habits laden with high calories, sugars, and fats, which when not counterbalanced with physical exercise, cause significant weight accumulation. Devices designed for diabetes treatment play a considerable role in mitigating obesity rates by enhancing blood sugar regulation, thereby encouraging positive lifestyle changes and effective weight administration. For example, in September 2023, the Centers for Disease Control and Prevention, which is a US government institution, indicated that in 2022, there were 22 American states with a 35% or higher obesity rate among adults, which was a rise from 19 states the previous year, 2021. Consequently, the rising rates of obesity are fueling the surge of the diabetes treatment devices market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

What Are the Key Segments Driving Diabetes Treatment Devices Market Growth?
The diabetes treatment devices market covered in this report is segmented -

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels
3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:
1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices
2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices
3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters
4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips
5) By Lancets: Standard Lancets, Safety Lancets
6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices
7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors
8) By Transmitters: Reusable Transmitters, Disposable Transmitters
9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers
10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

What Are the Technological Trends Impacting the Diabetes Treatment Devices Market?
Leading firms in the diabetes treatment devices market are concentrating on creating innovative products like hybrid closed-loop insulin pump systems to better regulate blood sugar levels and decrease the load of diabetes management for patients. A hybrid closed-loop insulin pump system is a cutting-edge diabetes tool which auto-calibrates insulin distribution based on the readings from a continuous glucose monitor (CGM), albeit necessitating manual input for insulin doses at meal times. For example, Medtronic PLC, an Ireland-based medical device manufacturer, introduced the MiniMed 780G system equipped with SmartGuard technology for managing type 1 diabetes in individuals between the ages of 7 to 80 years in March 2022. This revolutionary system autonomously regulates basal insulin and administers correction boluses every five minutes to retain glucose levels within a customized target range. It even compensates for forgotten meal boluses or misjudged carbohydrate amounts. The system also incorporates Meal Detection technology, a continuous glucose monitor that obviates the need for fingersticks, and an infusion set intended for a week's usage, all of which can be monitored and controlled through a connected mobile app.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Who Are the Major Competitors in the Global Diabetes Treatment Devices Market?
Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH

Which Region Dominates the Diabetes Treatment Devices Market Share in 2025?
North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.